Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2018-08, Vol.29 (8), p.1880-1882
Hauptverfasser:	Verstovsek, S., Subbiah, V., Masarova, L., Yin, C. Cameron, Tang, G., Manshouri, T., Asatiani, E., Daver, N.G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Eosinophilia - drug therapy Eosinophilia - genetics Humans Letters to the Editor Lymphoma - drug therapy Lymphoma - genetics Male Middle Aged Myeloproliferative Disorders - drug therapy Myeloproliferative Disorders - genetics Oncogene Proteins, Fusion - genetics Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 1 - genetics Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!